Who owns QuidelOrtho Corp (QDEL)? Elite investor 13F holders
4 tracked elite investors reported holding QuidelOrtho Corp as of 2026-06-30, including Rubric Capital, D.E. Shaw, GAMCO, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rubric Capital | QUIDELORTHO CORP | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 57909512.00 USD | 3306281.000000 | Shares | hold | Original filing |
| D.E. Shaw | QUIDELORTHO CORP | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4733131.00 USD | 270233.000000 | Shares | reduce | Original filing |
| GAMCO | QUIDELORTHO CORP | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 4400381.00 USD | 251235.000000 | Shares | reduce | Original filing |
| Tudor Investment | QUIDELORTHO CORP | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3414602.00 USD | 194953.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.